380 related articles for article (PubMed ID: 15824337)
1. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
[TBL] [Abstract][Full Text] [Related]
2. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
[TBL] [Abstract][Full Text] [Related]
3. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
Möller F; Poettgen J; Broemel F; Neuhaus A; Daumer M; Heesen C
Mult Scler; 2011 Aug; 17(8):1002-9. PubMed ID: 21561959
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
Jha A; Weintraub A; Allshouse A; Morey C; Cusick C; Kittelson J; Harrison-Felix C; Whiteneck G; Gerber D
J Head Trauma Rehabil; 2008; 23(1):52-63. PubMed ID: 18219235
[TBL] [Abstract][Full Text] [Related]
5. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
Rabkin JG; Gordon PH; McElhiney M; Rabkin R; Chew S; Mitsumoto H
Muscle Nerve; 2009 Mar; 39(3):297-303. PubMed ID: 19208404
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
7. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
[TBL] [Abstract][Full Text] [Related]
8. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
9. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
10. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
Chan KM; Strohschein FJ; Rydz D; Allidina A; Shuaib A; Westbury CF
Muscle Nerve; 2006 Jan; 33(1):138-41. PubMed ID: 16175627
[TBL] [Abstract][Full Text] [Related]
12. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG
Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846
[TBL] [Abstract][Full Text] [Related]
13. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
Vasconcelos OM; Prokhorenko OA; Salajegheh MK; Kelley KF; Livornese K; Olsen CH; Vo AH; Dalakas MC; Halstead LS; Jabbari B; Campbell WW
Neurology; 2007 May; 68(20):1680-6. PubMed ID: 17502549
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Modafinil for multiple sclerosis fatigue: does it work?
Littleton ET; Hobart JC; Palace J
Clin Neurol Neurosurg; 2010 Jan; 112(1):29-31. PubMed ID: 19837509
[TBL] [Abstract][Full Text] [Related]
16. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
[TBL] [Abstract][Full Text] [Related]
17. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
Dinges DF; Arora S; Darwish M; Niebler GE
Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
[TBL] [Abstract][Full Text] [Related]
19. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study.
Lundt L
J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145
[TBL] [Abstract][Full Text] [Related]
20. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients.
Brioschi A; Gramigna S; Werth E; Staub F; Ruffieux C; Bassetti C; Schluep M; Annoni JM
Eur Neurol; 2009; 62(4):243-9. PubMed ID: 19672078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
